1. 疾病领域
  2. 感染
  3. 病毒感染

Viral Infection  (病毒感染)

实验性病毒感染涉及在受控环境中研究病毒的致病机制,通常使用动物模型,以评估营养不良等因素如何影响病毒复制、疾病严重程度和免疫反应。免疫缺陷-65 (IMD65) 是一种常染色体隐性遗传疾病,其特征是婴儿期开始出现严重的病毒感染,由于 I 型干扰素信号传导缺陷,导致反复肺炎、支气管扩张和感染性休克。关键的实验室特征包括淋巴细胞减少、低丙种球蛋白血症和抗病毒免疫力受损。静脉注射免疫球蛋白治疗具有临床益处,而减毒活疫苗是禁用的,因为干扰素反应受损的患者存在疫苗株传播的风险。

Experimental viral infection involves studying viral pathogenesis in controlled environments, typically using animal models, to assess how factors like malnutrition influence viral replication, disease severity, and immune responses. Immunodeficiency-65 (IMD65) is an autosomal recessive disorder marked by severe viral infections beginning in infancy, leading to recurrent pneumonia, bronchiectasis, and septic shock due to defective type I interferon signaling. Key laboratory features include lymphopenia, hypogammaglobulinemia, and impaired antiviral immunity. Intravenous immunoglobulin therapy provides clinical benefit, while live attenuated vaccines are contraindicated due to the risk of vaccine-strain dissemination in patients with compromised interferon responses.

Viral Infection (1):

Cat. No. Product Name CAS No. Purity Chemical Structure
  • HY-13637S
    Ganciclovir-d5

    更昔洛韦 d5

    1189966-73-1 98.32%
    Ganciclovir-d5 是 Ganciclovir 的氘代物。Ganciclovir (BW 759) 是一种核苷类似物和口服抗病毒活性分子,对 CMV 具有抗病毒活性。Ganciclovir 在体外对疱疹病毒 (herpes group) 和其他一些 DNA 病毒也具有抗病毒活性。Ganciclovir 抑制人类疱疹病毒 (HSV 1 型和 2 型,CMV) 和腺病毒血清型1、2、4、6、8、10、19、22 和 28 的体外复制。Ganciclovir 对猫 1 型疱疹病毒 (FHV-1) 的IC50为 5.2 μM。
    Ganciclovir-d<sub>5</sub>